The association between high levels of IL-6 and lower survival was also observed in patients with renal cell carcinoma [41], chronic lymphocytic leukemia [42], gastric carcinoma [43], prostate cancer [44], gastrointestinal cancer [45] and breast cancer [46]. This evidence concerns the gene IL6 and breast carcinoma.